Skip to main content

Table 4 Relationships between mutations and MSI patterns by histological subtype

From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma

MSI status PTC FTC Benign
N (%) p* N (%) p* N (%)
MSI 59/70 (84%) 0.002 11/12 (92%) 0.012 6/14 (43%)
  MSI-H 38/59 (64%)   9/11 (82%)   -
  MSI-L 21/59 (46%) 2/11 (18%) 6/6 (100%)
  1. * p values compared against the benign group.